Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Tuesday's After-Market Session

Author: Benzinga Insights | May 06, 2025 05:06pm

Gainers

  • Lipocine (NASDAQ:LPCN) shares rose 15.1% to $3.66 during Tuesday's after-market session. The company's market cap stands at $19.5 million.
  • Cumberland (NASDAQ:CPIX) shares increased by 11.11% to $4.9. The market value of their outstanding shares is at $68.4 million. As per the news, the Q1 earnings report came out today.
  • Rigel Pharmaceuticals (NASDAQ:RIGL) shares moved upwards by 10.89% to $20.25. The market value of their outstanding shares is at $356.7 million. The company's, Q1 earnings came out today.
  • Harvard Bioscience (NASDAQ:HBIO) stock moved upwards by 10.0% to $0.33. The company's market cap stands at $14.5 million.
  • OneMedNet (NASDAQ:ONMD) shares moved upwards by 9.84% to $0.42. The company's market cap stands at $11.8 million.
  • Biodesix (NASDAQ:BDSX) shares rose 9.35% to $0.49. The market value of their outstanding shares is at $71.1 million.

Losers

  • Sarepta Therapeutics (NASDAQ:SRPT) stock fell 20.7% to $37.0 during Tuesday's after-market session. The company's market cap stands at $3.6 billion. The company's, Q1 earnings came out today.
  • Myriad Genetics (NASDAQ:MYGN) stock decreased by 18.44% to $5.93. The company's market cap stands at $546.5 million. As per the news, the Q1 earnings report came out today.
  • AquaBounty Techs (NASDAQ:AQB) shares decreased by 16.87% to $0.78. The market value of their outstanding shares is at $3.0 million.
  • Evoke Pharma (NASDAQ:EVOK) stock fell 8.82% to $3.0. The company's market cap stands at $4.4 million.
  • Tharimmune (NASDAQ:THAR) stock fell 8.49% to $1.51. The market value of their outstanding shares is at $2.9 million.
  • 180 Life Sciences (NASDAQ:ATNF) shares fell 8.48% to $1.08. The company's market cap stands at $4.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AQB ATNF BDSX CPIX EVOK HBIO LPCN MYGN ONMD RIGL SRPT THAR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist